Central Nervous System Efficacy of Capmatinib in NSCLC With Brain Metastases With cfDNA Positive MET Alterations
Clinical trial NCT05567055 · WITHDRAWN
Trial details
- NCT number
- NCT05567055
- Sponsor
- Timothy Burns, MD, PHD
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-03
- Primary completion
- 2026-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.